NASDAQ:RMTI Rockwell Medical Q3 2026 Earnings Date & Estimates $7.07 -0.24 (-3.28%) Closing price 04:00 PM EasternExtended Trading$7.02 -0.06 (-0.78%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Rockwell Medical is scheduled to report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Rockwell Medical in Q3 2026Rockwell Medical is expected to post earnings of -$0.13 per share on revenue of $18.22 million. Rockwell Medical last reported on August 13, 2026, posting -$0.34 per share and missing the -$0.2350 consensus estimate. Rockwell Medical has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.13Expected Revenue$18.22 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.34 (Missed by -$0.1050)Last Quarter Revenue$17.78 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Rockwell Medical Q3 2026 Earnings FAQ When does Rockwell Medical report Q3 2026 earnings? Rockwell Medical (NASDAQ:RMTI) has confirmed it will report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. What time is Rockwell Medical's Q3 2026 earnings call? Rockwell Medical's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Rockwell Medical? Analysts expect Rockwell Medical to post earnings of -$0.13 per share for Q3 2026. How much revenue is Rockwell Medical expected to report? The consensus revenue estimate for Rockwell Medical is $18.22 million for Q3 2026. Rockwell Medical Earnings HeadlinesRockwell Medical (NASDAQ:RMTI) Share Price Breaks Above 200-Day Moving Average - Time to Sell?October 24, 2026 | americanbankingnews.comRockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026October 15, 2026 | businesswire.comDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long. Tradewins plans to move the resource behind a paywall soon, closing off free access to the strategy breakdown. Readers who want a copy should grab it now, before the download link expires.October 30 at 1:00 AM | TradeWins (Ad)Rockwell Medical to Exhibit at ASN Kidney Week 2026October 14, 2026 | businesswire.comRockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production’ ListOctober 7, 2026 | finance.yahoo.comRockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' ListOctober 7, 2026 | businesswire.comSee More Rockwell Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Rockwell Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rockwell Medical and other key companies, straight to your email. Email Address About Rockwell MedicalRockwell Medical (NASDAQ:RMTI) is a healthcare company focused on developing, manufacturing and commercializing products used in the treatment of patients with end-stage renal disease (ESRD) who receive hemodialysis. The company supplies products intended to support anemia management and other aspects of dialysis care. Its principal pharmaceutical product is Triferic, an iron replacement therapy designed to deliver iron to hemodialysis patients through the dialysate. Rockwell Medical also markets Triferic AVNU, an intravenous formulation administered during hemodialysis. In addition, the company produces dialysis concentrates, including acid and bicarbonate concentrates used by dialysis providers to prepare dialysate. Rockwell Medical was established in 1996 and is headquartered in Wixom, Michigan. Its commercial activities have primarily focused on the United States dialysis market, with products and partnerships supporting access to dialysis care in other markets. The company serves dialysis providers, healthcare organizations and pharmaceutical customers.View Rockwell Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Silicon Shock: Intel's 25% Valuation ResetDoorDash's $17 Billion Bet on Instacart Faces a Long Regulatory Road AheadAmazon's Record Margins Couldn't Stop the Sell-Off—Here's WhyBreaching the Valuation: The Real Reason Fortinet DroppedMicrosoft Earnings Expose a Growing Divide in the Magnificent 7 AI TradeWhere's the Beef? Trian-Led Buyout Proposal Values Wendy's at $1.4B, But Is It Enough?Chipotle's $32 Floor: Is a Major Stock Rebound Coming? Upcoming Earnings Marriott International (11/2/2026)Diamondback Energy (11/2/2026)Williams Companies (11/2/2026)Vertex Pharmaceuticals (11/2/2026)Realty Income (11/2/2026)Apple (11/2/2026)Palantir Technologies (11/2/2026)Entergy (11/2/2026)Booking (11/3/2026)Ferrari (11/3/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
